BD

Health, Medical, & Dental Supplies and Equipment

BD U-500 Insulin Syringe for avoiding dosing errors.

Developed for diabetic people who take Humulin R U-500 insulin, BD U-500 Insulin Syringe prevents confusion due to more steps and incorrect dosing. Having measurement of 6mm x 31-gauge syringe needle minimises risk of intramuscular injection. Product is 0.5mL syringe with clear, bold U-500 scale markings in 5-unit increments allowing dosing up to 250 units. Product is color coded to match Humulin...

Read More »
Laboratory and Research Supplies and Equipment

Automated ID/AST System combats antimicrobial resistance.

Used for bacterial identification and antimicrobial susceptibility testing (ID/AST), BD Phoenix™ M50 benefits from performance of BD Phoenix 100 system for detecting current and emerging resistances as well as testing capabilities provided by BD Phoenix Emerge AST panel with 136 wells. Integration with multiple other analyzers through BD EpiCenter™ middleware connectivity enables data...

Read More »
Health, Medical, & Dental Supplies and Equipment

BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial

BD ChloraShield™ Dressings are Now Available for a Range of Vascular Access Procedures FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies™, an Avery Dennison (NYSE:AVY) business, today launched a line of transparent vascular dressings with chlorhexidine gluconate (CHG) antimicrobial preservative that are designed to enhance patient care...

Read More »
Health, Medical, & Dental Supplies and Equipment

Surgical Instrument Containers withstand low-temperature systems.

Validated for low-temperature sterilization processes and systems, including V-PRO® and STERRAD®, Genesis™ Low Temperature Rigid Sterilization Containers help protect and organize heat- and moisture-sensitive surgical instrumentation during low-temperature hydrogen-peroxide sterilization. Products, identifiableÂ- by their orange gaskets, handles, and ID tags, are also...

Read More »
Material Handling & Storage

BD Receives FDA Approval for New Automated Cervical Cancer Screening System

Adds BD Totalys™ MultiProcessor and BD Totalys™ SlidePrep for Gynecological Specimen Preparation to Cytology Instrumentation Portfolio FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for itsÂ-  BD Totalys™ MultiProcessor and BD Totalys™...

Read More »
Laboratory and Research Supplies and Equipment

High-Speed Analyzer helps identify rare cell types/events.

While offering high-speed analysis with detection rates of up to 40,000 events/sec, BD FACSymphony™ enables simultaneous measurement of up to 50 different characteristics of one cell. Ultra-quiet electronics system improves detection sensitivity, and configurable options let operators fully leverage BD Horizon Brilliant™ reagents. Together, capabilities allow researchers to conduct deep...

Read More »
Test & Measurement

Flow Cytometer targets research segment.

Designed to leverage BD Horizon Brilliant™ reagent portfolio, BD FACSCelesta™ system offers simultaneous measurement of up to 14 different single cell characteristics. Three-laser benchtop system is available in multiple configurations, delivering performance required for varied immunology and cell biology applications. System can help simplify experimental design and analysis for experienced...

Read More »
Fluid & Gas Flow Equipment

BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart(TM) Technology Designed to Improve Insulin Pump Therapy

New Innovation Demonstrates Reductions in Flow Interruptions, Including Silent Occlusions BOSTONÂ- — BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a collaboration to introduce a new insulin pump infusion set with BD FlowSmart™ technology. An insulin infusion set delivers insulin...

Read More »
Controls & Controllers

BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing

SAN JOSE, Calif.Â- – BD Life Sciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Cellular Research, an innovative company focused on enabling high-resolution biology, today announced that they will be jointly promoting their unique solutions for highly multiplexed cell isolation and single-cell gene expression analysis....

Read More »
Health, Medical, & Dental Supplies and Equipment

The BD(TM) Intelliport® Medication Management System Receives Clearance from the Food and Drug Administration (FDA)

First-of-its-kind medication management solution for manual IV bolus injections expected to be available commercially in spring 2015 FRANKLIN LAKES, N.J.Â- – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the BD™ Intelliport® Medication...

Read More »
Health, Medical, & Dental Supplies and Equipment

BD U-500 Insulin Syringe for avoiding dosing errors.

Developed for diabetic people who take Humulin R U-500 insulin, BD U-500 Insulin Syringe prevents confusion due to more steps and incorrect dosing. Having measurement of 6mm x 31-gauge syringe needle minimises risk of intramuscular injection. Product is 0.5mL syringe with clear, bold U-500 scale markings in 5-unit increments allowing dosing up to 250 units. Product is color coded to match Humulin...

Read More »
Laboratory and Research Supplies and Equipment

Automated ID/AST System combats antimicrobial resistance.

Used for bacterial identification and antimicrobial susceptibility testing (ID/AST), BD Phoenix™ M50 benefits from performance of BD Phoenix 100 system for detecting current and emerging resistances as well as testing capabilities provided by BD Phoenix Emerge AST panel with 136 wells. Integration with multiple other analyzers through BD EpiCenter™ middleware connectivity enables data...

Read More »
Health, Medical, & Dental Supplies and Equipment

BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial

BD ChloraShield™ Dressings are Now Available for a Range of Vascular Access Procedures FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) (NYSE: BDX) and Vancive Medical Technologies™, an Avery Dennison (NYSE:AVY) business, today launched a line of transparent vascular dressings with chlorhexidine gluconate (CHG) antimicrobial preservative that are designed to enhance patient care...

Read More »
Health, Medical, & Dental Supplies and Equipment

Surgical Instrument Containers withstand low-temperature systems.

Validated for low-temperature sterilization processes and systems, including V-PRO® and STERRAD®, Genesis™ Low Temperature Rigid Sterilization Containers help protect and organize heat- and moisture-sensitive surgical instrumentation during low-temperature hydrogen-peroxide sterilization. Products, identifiableÂ- by their orange gaskets, handles, and ID tags, are also...

Read More »
Material Handling & Storage

BD Receives FDA Approval for New Automated Cervical Cancer Screening System

Adds BD Totalys™ MultiProcessor and BD Totalys™ SlidePrep for Gynecological Specimen Preparation to Cytology Instrumentation Portfolio FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for itsÂ-  BD Totalys™ MultiProcessor and BD Totalys™...

Read More »
Laboratory and Research Supplies and Equipment

High-Speed Analyzer helps identify rare cell types/events.

While offering high-speed analysis with detection rates of up to 40,000 events/sec, BD FACSymphony™ enables simultaneous measurement of up to 50 different characteristics of one cell. Ultra-quiet electronics system improves detection sensitivity, and configurable options let operators fully leverage BD Horizon Brilliant™ reagents. Together, capabilities allow researchers to conduct deep...

Read More »
Test & Measurement

Flow Cytometer targets research segment.

Designed to leverage BD Horizon Brilliant™ reagent portfolio, BD FACSCelesta™ system offers simultaneous measurement of up to 14 different single cell characteristics. Three-laser benchtop system is available in multiple configurations, delivering performance required for varied immunology and cell biology applications. System can help simplify experimental design and analysis for experienced...

Read More »
Mergers & Acquisitions

BD to Acquire Cellular Research to Develop a Leading Genomics Platform for Single Cell Analysis

FRANKLIN LAKES, N.J. –Â- BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed the acquisition of Cellular Research, Inc. BD is a global leader in characterizing and isolating single cells for analysis, with more than 30 years of experience in developing cell sorting technologies, known...

Read More »
Fluid & Gas Flow Equipment

BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart(TM) Technology Designed to Improve Insulin Pump Therapy

New Innovation Demonstrates Reductions in Flow Interruptions, Including Silent Occlusions BOSTONÂ- — BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a collaboration to introduce a new insulin pump infusion set with BD FlowSmart™ technology. An insulin infusion set delivers insulin...

Read More »
Mergers & Acquisitions

Becton Dickinson Completes Acquisition of CareFusion

FRANKLIN LAKES, N.J. –Â- Becton, Dickinson and Company (NYSE: BDX) ( BD") today announced that it completed its acquisition of CareFusion Corporation ("CareFusion") pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement"). Vincent A. Forlenza, BD's Chairman, Chief Executive Officer and President, said, "We are very...

Read More »

All Topics